The Prostate 2023 May 27
First, do no harm: The unclear benefit of lifelong castration for patients with metastatic prostate cancer.   

Related Questions

Long-term ADT is deleterious to multiple organ systems (bone/sexual/psychiatric) and increases the risk of MACE. What level 1 evidence do we have to c...